JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB51103

Anti-Ret (phospho Y1062) antibody

Be the first to review this product! Submit a review

|

(15 Publications)

Rabbit Polyclonal RET phospho Y1062 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 15 publications. Immunogen corresponding to Synthetic Peptide within Human RET pY1062 aa 1000-1100.

View Alternative Names

CDHF12, CDHR16, PTC, RET, RET51, Proto-oncogene tyrosine-protein kinase receptor Ret, Cadherin family member 12, Proto-oncogene c-Ret

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ret (phospho Y1062) antibody (AB51103)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ret (phospho Y1062) antibody (AB51103)

ab51103 staining human normal testis tissue. Staining is localised to cell membranes.
Left panel : with primary antibody at 1 ug/ml. Right panel : isotype control.
Sections were stained using an automated system (DAKO Autostainer Plus), at room temperature : sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

Western blot - Anti-Ret (phospho Y1062) antibody (AB51103)
  • WB

Unknown

Western blot - Anti-Ret (phospho Y1062) antibody (AB51103)

All lanes:

Western blot - Anti-Ret (phospho Y1062) antibody (ab51103) at 1/500 dilution

Lane 1:

K562 cell lysate.

Lane 2:

K562 cell Lysate. For this panel, ab51103 was pre-incubated with immunizing peptide.

Predicted band size: 124 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

Synthetic Peptide within Human RET pY1062 aa 1000-1100. The exact immunogen used to generate this antibody is proprietary information.

P07949

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab51103 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Ret also known as "rearranged during transfection" is a receptor tyrosine kinase with a mass of approximately 170-175 kDa. Scientists often study Ret because of its key role in cellular signaling pathways. It is primarily expressed in neural crest-derived cells and tissues including the kidneys and the enteric nervous system. Ret is also found in various other cell types throughout the body such as endocrine and hematopoietic tissues.
Biological function summary

The Ret protein facilitates several critical processes within the body. It functions as part of a complex with co-receptors called GFRα (GDNF family receptor alpha) which are required for binding ligands such as GDNF (glial cell line-derived neurotrophic factor). This binding activates downstream signaling pathways that influence cell growth differentiation and survival particularly within the nervous system. The proper functioning of Ret is essential for the development and maintenance of these cellular environments.

Pathways

Ret is an important component of the MAPK/ERK and PI3K/AKT signaling pathways. These pathways mediate various cellular responses including cell proliferation survival and apoptosis. The interactions of Ret with other proteins like SHC and GRB2 within these pathways create ripple effects that impact larger cellular networks. Through these pathways Ret connects with multiple proteins to modulate essential biological processes.

Ret's dysregulation is closely associated with multiple endocrine neoplasia type 2 (MEN2) and Hirschsprung's disease. These conditions arise due to mutations affecting Ret's signaling capabilities. In MEN2 Ret mutations lead to uncontrolled cell growth often resulting in medullary thyroid carcinoma. Hirschsprung's disease on the other hand involves a failure in neural crest cell migration leading to congenital gut motility issues. Researchers explore Ret's interactions with other proteins such as endothelin receptor B (EDNRB) to further understand these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation in response to glia cell line-derived growth family factors (GDNF, NRTN, ARTN, PSPN and GDF15) (PubMed : 20064382, PubMed : 20616503, PubMed : 20702524, PubMed : 21357690, PubMed : 21454698, PubMed : 24560924, PubMed : 28846097, PubMed : 28846099, PubMed : 28953886, PubMed : 31118272). In contrast to most receptor tyrosine kinases, RET requires not only its cognate ligands but also coreceptors, for activation (PubMed : 21994944, PubMed : 23333276, PubMed : 28846097, PubMed : 28846099, PubMed : 28953886). GDNF ligands (GDNF, NRTN, ARTN, PSPN and GDF15) first bind their corresponding GDNFR coreceptors (GFRA1, GFRA2, GFRA3, GFRA4 and GFRAL, respectively), triggering RET autophosphorylation and activation, leading to activation of downstream signaling pathways, including the MAPK- and AKT-signaling pathways (PubMed : 21994944, PubMed : 23333276, PubMed : 24560924, PubMed : 25242331, PubMed : 28846097, PubMed : 28846099, PubMed : 28953886). Acts as a dependence receptor via the GDNF-GFRA1 signaling : in the presence of the ligand GDNF in somatotrophs within pituitary, promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF (PubMed : 20616503, PubMed : 21994944). Required for the molecular mechanisms orchestration during intestine organogenesis via the ARTN-GFRA3 signaling : involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue (By similarity). Mediates, through interaction with GDF15-receptor GFRAL, GDF15-induced cell-signaling in the brainstem which triggers an aversive response, characterized by nausea, vomiting, and/or loss of appetite in response to various stresses (PubMed : 28846097, PubMed : 28846099, PubMed : 28953886). Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner (PubMed : 20702524, PubMed : 21357690). Also active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage (PubMed : 21357690). Triggers the differentiation of rapidly adapting (RA) mechanoreceptors (PubMed : 20064382). Involved in the development of the neural crest (By similarity). Regulates nociceptor survival and size (By similarity). Phosphorylates PTK2/FAK1 (PubMed : 21454698).. Isoform 1. Isoform 1 in complex with GFRAL induces higher activation of MAPK-signaling pathway than isoform 2 in complex with GFRAL.
See full target information RET pY1062

Publications (15)

Recent publications for all applications. Explore the full list and refine your search

Experimental & molecular medicine 57:2264-2276 PubMed41034527

2025

GDF15 regulates development and growth of sympathetic neurons to enhance energy expenditure and thermogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Jinyoung Kim,Annie Zhao,Seo Hyun Park,Jaeseok Han,Deok-Hyeon Cheon,Sang-Hyeon Ju,Yoonhyuk Jang,Kon Chu,Hyung Jin Choi,Jiyoon Kim,Myung-Shik Lee

Burns & trauma 13:tkaf012 PubMed40568374

2025

AT-rich interaction domain 5A facilitates axon regeneration through docking protein 6 in the peripheral nervous system.

Applications

Unspecified application

Species

Unspecified reactive species

Zhixian Ren,Weixiao Huang,Xiaosong Gu,Lili Zhao

Cell reports 42:113070 PubMed37659079

2023

TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation.

Applications

Unspecified application

Species

Unspecified reactive species

Qianjin Guo,Zi-Ming Cheng,Hector Gonzalez-Cantú,Matthew Rotondi,Gabriela Huelgas-Morales,Purushoth Ethiraj,Zhijun Qiu,Jonathan Lefkowitz,Wan Song,Bethany N Landry,Hector Lopez,Cynthia M Estrada-Zuniga,Shivi Goyal,Mohammad Aasif Khan,Timothy J Walker,Exing Wang,Faqian Li,Yanli Ding,Lois M Mulligan,Ricardo C T Aguiar,Patricia L M Dahia

JCO precision oncology 7:e2300052 PubMed37535881

2023

D898_E901 Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

Tommaso Porcelli,Marialuisa Moccia,Maria Angela De Stefano,Raffaele Ambrosio,Ettore Capoluongo,Massimo Santoro,Julien Hadoux,Martin Schlumberger,Francesca Carlomagno,Domenico Salvatore

Cancer research 83:3237-3251 PubMed37071495

2023

Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xuxu Gou,Beom-Jun Kim,Meenakshi Anurag,Jonathan T Lei,Meggie N Young,Matthew V Holt,Diana Fandino,Craig T Vollert,Purba Singh,Mohammad A Alzubi,Anna Malovannaya,Lacey E Dobrolecki,Michael T Lewis,Shunqiang Li,Charles E Foulds,Matthew J Ellis

Cell reports. Medicine 3:100686 PubMed35858593

2022

A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions.

Applications

Unspecified application

Species

Unspecified reactive species

Cynthia M Estrada-Zuniga,Zi-Ming Cheng,Purushoth Ethiraj,Qianjin Guo,Hector Gonzalez-Cantú,Elaina Adderley,Hector Lopez,Bethany N Landry,Abir Zainal,Neil Aronin,Yanli Ding,Xiaojing Wang,Ricardo C T Aguiar,Patricia L M Dahia

Cancer research 82:3143-3157 PubMed35705526

2022

MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET.

Applications

Unspecified application

Species

Unspecified reactive species

Ankit Srivastava,Cristina Tommasi,Dane Sessions,Angela Mah,Tomas Bencomo,Jasmine M Garcia,Tiffany Jiang,Michael Lee,Joseph Y Shen,Lek Wei Seow,Audrey Nguyen,Kimal Rajapakshe,Cristian Coarfa,Kenneth Y Tsai,Vanessa Lopez-Pajares,Carolyn S Lee

Cell death & disease 13:351 PubMed35428350

2022

EGFR/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli.

Applications

Unspecified application

Species

Unspecified reactive species

Shouyang Song,Zhen Yu,Yajing You,Chenxi Liu,Xiaoyu Xie,Huanran Lv,Feng Xiao,Qiang Zhu,Chengyong Qin

Biochemistry and cell biology = Biochimie et biolo 98:443-448 PubMed32449862

2020

YAP confers resistance to vandetanib in medullary thyroid cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Huan Wang,Jian Tang,Zhiwei Su

Oncology reports 44:263-272 PubMed32319659

2020

RET receptor expression and interaction with TRK receptors in neuroblastomas.

Applications

Unspecified application

Species

Unspecified reactive species

Laura H Tetri,Venkatadri Kolla,Rebecca L Golden,Radhika Iyer,Jamie L Croucher,Jee-Hye Choi,Suzanne P Macfarland,Koumudi Naraparaju,Peng Guan,Ferro Nguyen,Krutika S Gaonkar,Pichai Raman,Garrett M Brodeur
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com